Terumo BCT

UNLOCKING THE POTENTIAL OF BLOOD

[ { "thumbSrc": "/PublishingImages/carousel/CSR-Report-thumb.gif", "imgSrc": "/PublishingImages/carousel/CSR-Report.jpg", "linkSrc": "/about-us/corporate-responsibility", "color": "#009a44", "title1": "Global Connection:", "description1": "Learn About Our", "description2": "Commitment to Social Responsibility" }, { "thumbSrc": "/_catalogs/masterpage/dotcom/img/carousel/thumbs/immuno.jpg", "imgSrc": "/PublishingImages/carousel/immuno.jpg", "linkSrc": "/cell-therapy-technologies/immunotherapy", "color": "#ff7900", "title1": "Immunotherapy:", "description1": "", "description2": "Enabling Next-Generation Cancer Treatments" }, { "thumbSrc": "/_catalogs/masterpage/dotcom/img/carousel/thumbs/ts.jpg", "imgSrc": "/PublishingImages/carousel/ts.jpg", "linkSrc": "/therapeutic-apheresis", "color": "#aa6dab", "title1": "Advancing Apheresis:", "description1": "", "description2": "More Treatment Options for More Patients" }, { "thumbSrc": "/_catalogs/masterpage/dotcom/img/carousel/thumbs/contract-manufacturing.jpg", "imgSrc": "/PublishingImages/carousel/contract-manufacturing.jpg", "linkSrc": "/contract-manufacturing", "color": "#447ebc", "title1": "Contract Manufacturing:", "description1": "", "description2": "Only the Right Team and the Right Facility Will Do" }, { "thumbSrc": "/_catalogs/masterpage/dotcom/img/carousel/thumbs/bcs-sw.jpg", "imgSrc": "/PublishingImages/carousel/bcs-sw.jpg", "linkSrc": "/blood-center-services", "color": "#447ebc", "title1": "The Power to Perform", "description1": "", "description2": "Helping Blood Centers With Their Toughest Challenges" } ]

QUICK LINKS

Get Product Support Find Technical Documents Find Certificates of Compliance Get Training Start a Career With Us

LATEST NEWS

Keep Pace With the Pulse of Change
We are at ISBT: visit us at booth 622.
To stay ahead of the curve, register now for an in-booth demo.

New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments

Terumo BCT Announces Enrollment of the First Patient in Its U.S. Clinical Trial Designed to Study Platelets Treated With the Mirasol^® Pathogen Reduction Technology (PRT) System

Collaborative Global Effort to Advance Blood Safety Moves Forward Across Ghana

Terumo BCT's Spectra Optia^® Apheresis System Is the First and Only Device on the European Market Indicated to Treat Guillain-Barré Syndrome and Myasthenia Gravis using Therapeutic Plasma Exchange

UNLOCKING THE POTENTIAL OF BLOOD

{{$index+1}}. {{s.label}}

LATEST NEWS

Keep Pace With the Pulse of ChangeWe are at ISBT: visit us at booth 622.To stay ahead of the curve, register now for an in-booth demo.

New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments

Terumo BCT Announces Enrollment of the First Patient in Its U.S. Clinical Trial Designed to Study Platelets Treated With the Mirasol® Pathogen Reduction Technology (PRT) System

Collaborative Global Effort to Advance Blood Safety Moves Forward Across Ghana

Terumo BCT's Spectra Optia® Apheresis System Is the First and Only Device on the European Market Indicated to Treat Guillain-Barré Syndrome and Myasthenia Gravis using Therapeutic Plasma Exchange

Keep Pace With the Pulse of Change
We are at ISBT: visit us at booth 622.
To stay ahead of the curve, register now for an in-booth demo.

Terumo BCT Announces Enrollment of the First Patient in Its U.S. Clinical Trial Designed to Study Platelets Treated With the Mirasol^® Pathogen Reduction Technology (PRT) System

Terumo BCT's Spectra Optia^® Apheresis System Is the First and Only Device on the European Market Indicated to Treat Guillain-Barré Syndrome and Myasthenia Gravis using Therapeutic Plasma Exchange